Aprogen Medicines Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 11.3%.

Top 17 shareholders own 52.16% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
27%	G-Baise Inc.	71,783,159	₩84.1b	0%	no data
9.95%	Nexkonics Inc.	26,470,423	₩31.0b	0%	no data
5.01%	Jae-Seob Kim	13,328,002	₩15.6b	0%	no data
4.7%	Nichi-Iko Pharmaceutical Co., Ltd.	12,495,499	₩14.6b	0%	no data
2.53%	Miryeong Park	6,739,068	₩7.9b	0%	no data
0.82%	Sangsangin Plus Savings Bank, Asset Management Arm	2,191,060	₩2.6b	0%	50.01%
0.82%	Sangsangin Savings Bank, Asset Management Arm	2,191,060	₩2.6b	0%	18.53%
0.57%	Samsung Asset Management Company, Ltd.	1,526,575	₩1.8b	194%	0.01%
0.42%	Jung-Chul Kim	1,123,427	₩1.3b	0%	no data
0.22%	Dimensional Fund Advisors LP	575,347	₩673.7m	45.3%	no data
0.074%	Seon-ju Kang	198,187	₩232.1m	0%	no data
0.032%	State Street Global Advisors, Inc.	86,293	₩101.1m	3.56%	no data
0.012%	KB Asset Management Co., Ltd.	31,835	₩37.3m	0%	no data
0.0076%	Mirae Asset Global Investments Co., Ltd.	20,140	₩23.6m	0%	no data
0.0074%	American Century Investment Management Inc	19,621	₩23.0m	-0.01%	no data
0.00045%	Invesco Capital Management LLC	1,191	₩1.4m	0%	no data
0.00007%	Korea Investment Management Co., Ltd.	195	₩218.1k	0%	no data